This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Negrea, A.
Right arrow Articles by Rhen, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Negrea, A.
Right arrow Articles by Rhen, M.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 2007, p. 2867-2876, Vol. 51, No. 8
0066-4804/07/$08.00+0     doi:10.1128/AAC.00223-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Salicylidene Acylhydrazides That Affect Type III Protein Secretion in Salmonella enterica Serovar Typhimurium{triangledown}

Aurel Negrea,1 Eva Bjur,1 Sofia Eriksson Ygberg,2 Mikael Elofsson,3 Hans Wolf-Watz,4 and Mikael Rhen1*

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Nobels väg 16, 171 77 Stockholm, Sweden,1 The Swedish Institute for Infectious Disease Control, Nobels väg 18, 171 82 Solna, Sweden,2 Organic Chemistry, Department of Chemistry, Umeå University, SE-90187 Umeå, Sweden,3 Department of Molecular Biology, Umeå University, SE-90187 Umeå, Sweden4

Received 14 February 2007/ Returned for modification 19 April 2007/ Accepted 26 May 2007

A collection of nine salicylidene acylhydrazide compounds were tested for their ability to inhibit the activity of virulence-associated type III secretion systems (T3SSs) in Salmonella enterica serovar Typhimurium. The compounds strongly affected Salmonella pathogenicity island 1 (SPI1) T3SS-mediated invasion of epithelial cells and in vitro secretion of SPI1 invasion-associated effector proteins. The use of a SPI1 effector ß-lactamase fusion protein implicated intracellular entrapment of the protein construct upon application of a salicylidene acylhydrazide, whereas the use of chromosomal transcriptional gene fusions revealed a compound-mediated transcriptional silencing of SPI1. Salicylidene acylhydrazides also affected intracellular bacterial replication in murine macrophage-like cells and blocked the transport of an epitope-tagged SPI2 effector protein. Two of the compounds significantly inhibited bacterial motility and expression of extracellular flagellin. We conclude that salicylidene acylhydrazides affect bacterial T3SS activity in S. enterica and hence could be used as lead substances when designing specific inhibitors of bacterial T3SSs in order to pharmaceutically intervene with bacterial virulence.

* Corresponding author. Mailing address: Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Nobels väg 16, 171 77 Stockholm, Sweden. Phone: 46-8-524 8 6252. Fax: 46-8-330498. E-mail: Mikael.Rhen{at}ki.se

{triangledown} Published ahead of print on 4 June 2007.

Antimicrobial Agents and Chemotherapy, August 2007, p. 2867-2876, Vol. 51, No. 8
0066-4804/07/$08.00+0     doi:10.1128/AAC.00223-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Negrea, A., Bjur, E., Puiac, S., Ygberg, S. E., Aslund, F., Rhen, M. (2009). Thioredoxin 1 Participates in the Activity of the Salmonella enterica Serovar Typhimurium Pathogenicity Island 2 Type III Secretion System. J. Bacteriol. 191: 6918-6927 [Abstract] [Full Text]  
  • Stevens, M. P., Humphrey, T. J., Maskell, D. J. (2009). Molecular insights into farm animal and zoonotic Salmonella infections. Phil Trans R Soc B 364: 2709-2723 [Abstract] [Full Text]  
  • Puiac, S., Negrea, A., Richter-Dahlfors, A., Plant, L., Rhen, M. (2009). Omeprazole Antagonizes Virulence and Inflammation in Salmonella enterica-Infected RAW264.7 Cells. Antimicrob. Agents Chemother. 53: 2402-2409 [Abstract] [Full Text]  
  • Pan, N. J., Brady, M. J., Leong, J. M., Goguen, J. D. (2009). Targeting Type III Secretion in Yersinia pestis. Antimicrob. Agents Chemother. 53: 385-392 [Abstract] [Full Text]  
  • Veenendaal, A. K. J., Sundin, C., Blocker, A. J. (2009). Small-Molecule Type III Secretion System Inhibitors Block Assembly of the Shigella Type III Secreton. J. Bacteriol. 191: 563-570 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»